These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 12697866

  • 1. Randomized phase I trial of recombinant human keratinocyte growth factor plus chemotherapy: potential role as mucosal protectant.
    Meropol NJ, Somer RA, Gutheil J, Pelley RJ, Modiano MR, Rowinsky EK, Rothenberg ML, Redding SW, Serdar CM, Yao B, Heard R, Rosen LS.
    J Clin Oncol; 2003 Apr 15; 21(8):1452-8. PubMed ID: 12697866
    [Abstract] [Full Text] [Related]

  • 2. Palifermin reduces the incidence of oral mucositis in patients with metastatic colorectal cancer treated with fluorouracil-based chemotherapy.
    Rosen LS, Abdi E, Davis ID, Gutheil J, Schnell FM, Zalcberg J, Cesano A, Gayko U, Chen MG, Clarke S.
    J Clin Oncol; 2006 Nov 20; 24(33):5194-200. PubMed ID: 17075109
    [Abstract] [Full Text] [Related]

  • 3. Randomized multicenter phase II trial of bolus plus infusional fluorouracil/leucovorin compared with fluorouracil/leucovorin plus oxaliplatin as third-line treatment of patients with advanced colorectal cancer.
    Kemeny N, Garay CA, Gurtler J, Hochster H, Kennedy P, Benson A, Brandt DS, Polikoff J, Wertheim M, Shumaker G, Hallman D, Burger B, Gupta S.
    J Clin Oncol; 2004 Dec 01; 22(23):4753-61. PubMed ID: 15570076
    [Abstract] [Full Text] [Related]

  • 4. Phase I/II randomized trial evaluating the safety and clinical effects of repifermin administered to reduce mucositis in patients undergoing autologous hematopoietic stem cell transplantation.
    Freytes CO, Ratanatharathorn V, Taylor C, Abboud C, Chesser N, Restrepo A, Arango J, Odenheimer D.
    Clin Cancer Res; 2004 Dec 15; 10(24):8318-24. PubMed ID: 15623608
    [Abstract] [Full Text] [Related]

  • 5. Phase II study of palifermin and concurrent chemoradiation in head and neck squamous cell carcinoma.
    Brizel DM, Murphy BA, Rosenthal DI, Pandya KJ, Glück S, Brizel HE, Meredith RF, Berger D, Chen MG, Mendenhall W.
    J Clin Oncol; 2008 May 20; 26(15):2489-96. PubMed ID: 18487568
    [Abstract] [Full Text] [Related]

  • 6. Randomised study of tegafur and oral leucovorin versus intravenous 5-fluorouracil and leucovorin in patients with advanced colorectal cancer.
    Nogué M, Salud A, Batiste-Alentorn E, Saigí E, Losa F, Cirera L, Méndez M, Campos JM, Galan A, Escudero P, Arcusa A, Manzano H, de Mendizábal EV, de Olaguer JP, Boleda M, Guasch I, Vicente P.
    Eur J Cancer; 2005 Oct 20; 41(15):2241-9. PubMed ID: 16214045
    [Abstract] [Full Text] [Related]

  • 7. Phase I study of transforming growth factor-beta3 mouthwashes for prevention of chemotherapy-induced mucositis.
    Wymenga AN, van der Graaf WT, Hofstra LS, Spijkervet FK, Timens W, Timmer-Bosscha H, Sluiter WJ, van Buuren AH, Mulder NH, de Vries EG.
    Clin Cancer Res; 1999 Jun 20; 5(6):1363-8. PubMed ID: 10389920
    [Abstract] [Full Text] [Related]

  • 8. Double-blind, placebo-controlled, randomized study of chlorhexidine prophylaxis for 5-fluorouracil-based chemotherapy-induced oral mucositis with nonblinded randomized comparison to oral cooling (cryotherapy) in gastrointestinal malignancies.
    Sorensen JB, Skovsgaard T, Bork E, Damstrup L, Ingeberg S.
    Cancer; 2008 Apr 01; 112(7):1600-6. PubMed ID: 18300265
    [Abstract] [Full Text] [Related]

  • 9. [Relationship of serum level of dihydropyrimidine dehydrogenase and serum concentration of 5-fluorouracil to treatment response and adverse events in colorectal cancer patients].
    Dong QM, He YJ, Li S, Zhou ZM, Zhang L, Zhou ZW, Xia ZJ, Li YY.
    Ai Zheng; 2005 Apr 01; 24(4):483-7. PubMed ID: 15820075
    [Abstract] [Full Text] [Related]

  • 10. Phase III Southwest Oncology Group 9415/Intergroup 0153 randomized trial of fluorouracil, leucovorin, and levamisole versus fluorouracil continuous infusion and levamisole for adjuvant treatment of stage III and high-risk stage II colon cancer.
    Poplin EA, Benedetti JK, Estes NC, Haller DG, Mayer RJ, Goldberg RM, Weiss GR, Rivkin SE, Macdonald JS.
    J Clin Oncol; 2005 Mar 20; 23(9):1819-25. PubMed ID: 15774775
    [Abstract] [Full Text] [Related]

  • 11. Preoperative chemoradiotherapy for rectal cancer: randomized trial comparing oral uracil and tegafur and oral leucovorin vs. intravenous 5-fluorouracil and leucovorin.
    de la Torre A, García-Berrocal MI, Arias F, Mariño A, Valcárcel F, Magallón R, Regueiro CA, Romero J, Zapata I, de la Fuente C, Fernández-Lizarbe E, Vergara G, Belinchón B, Veiras M, Molerón R, Millán I.
    Int J Radiat Oncol Biol Phys; 2008 Jan 01; 70(1):102-10. PubMed ID: 17869446
    [Abstract] [Full Text] [Related]

  • 12. Paclitaxel and leucovorin-modulated infusional 5-fluorouracil combination chemotherapy for metastatic gastric cancer.
    Cho BC, Kim JH, Kim CB, Sohn JH, Choi HJ, Lee YC, Ahn JB.
    Oncol Rep; 2006 Mar 01; 15(3):621-7. PubMed ID: 16465422
    [Abstract] [Full Text] [Related]

  • 13. Oxaliplatin plus high-dose leucovorin and 5-fluorouracil (FOLFOX 4) in platinum-resistant and taxane-pretreated ovarian cancer: a phase II study.
    Pectasides D, Pectasides M, Farmakis D, Gaglia A, Koumarianou A, Nikolaou M, Koumpou M, Kountourakis P, Papaxoinis G, Mitrou P, Economopoulos T, Raptis SA.
    Gynecol Oncol; 2004 Oct 01; 95(1):165-72. PubMed ID: 15385127
    [Abstract] [Full Text] [Related]

  • 14. Effect of topical oral G-CSF on oral mucositis: a randomised placebo-controlled trial.
    Karthaus M, Rosenthal C, Huebner G, Paul H, Elser C, Hertenstein B, Krauter J, Scharmann T, Geissler RG, Heil G, Ganser A.
    Bone Marrow Transplant; 1998 Oct 01; 22(8):781-5. PubMed ID: 9827976
    [Abstract] [Full Text] [Related]

  • 15. Phase II trial of dose-dense paclitaxel, cisplatin, 5-fluorouracil, and leucovorin with filgrastim support in patients with squamous cell carcinoma of the head and neck.
    Hitt R, Jimeno A, Millán JM, Castellano D, Cortés-Funes H.
    Cancer; 2004 Aug 15; 101(4):768-75. PubMed ID: 15305408
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of an irinotecan plus bolus 5-fluorouracil and L-leucovorin regimen for metastatic colorectal cancer in Japanese patients: experience in a single institution in Japan.
    Yoshino T, Boku N, Onozawa Y, Hironaka S, Fukutomi A, Yamaguchi Y, Hasuike N, Yamazaki K, Machida N, Ono H.
    Jpn J Clin Oncol; 2007 Sep 15; 37(9):686-91. PubMed ID: 17720736
    [Abstract] [Full Text] [Related]

  • 17. Phase I/II study of oxaliplatin with weekly bolus fluorouracil and high-dose leucovorin (ROX) as first-line therapy for patients with colorectal cancer.
    Yamada Y, Ohtsu A, Boku N, Miyata Y, Shimada Y, Doi T, Muro K, Muto M, Hamaguchi T, Mera K, Yano T, Tanigawara Y, Shirao K.
    Jpn J Clin Oncol; 2006 Apr 15; 36(4):218-23. PubMed ID: 16684860
    [Abstract] [Full Text] [Related]

  • 18. Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up.
    Psyrri A, Kwong M, DiStasio S, Lekakis L, Kassar M, Sasaki C, Wilson LD, Haffty BG, Son YH, Ross DA, Weinberger PM, Chung GG, Zelterman D, Burtness BA, Cooper DL.
    J Clin Oncol; 2004 Aug 01; 22(15):3061-9. PubMed ID: 15284256
    [Abstract] [Full Text] [Related]

  • 19. Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: a trial of the gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer.
    Ducreux M, Ychou M, Laplanche A, Gamelin E, Lasser P, Husseini F, Quenet F, Viret F, Jacob JH, Boige V, Elias D, Delperro JR, Luboinski M, gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer.
    J Clin Oncol; 2005 Aug 01; 23(22):4881-7. PubMed ID: 16009952
    [Abstract] [Full Text] [Related]

  • 20. A dose escalation study of leucovorin (LV) and 48-hour continuous infusion of 5-fluorouracil in combination with cyclophosphamide and vinorelbine in pretreated patients with metastatic breast cancer.
    Kouroussis C, Kalbakis K, Androulakis N, Agelaki S, Vamvakas L, Malas K, Souglakos J, Vardakis N, Georgoulias V.
    Anticancer Res; 2004 Aug 01; 24(6):4217-21. PubMed ID: 15736475
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.